159 related articles for article (PubMed ID: 31213431)
1. Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.
Rhee JY; Tremblay D; Chan AM; Tallman MS; Mascarenhas J
Blood Adv; 2019 Jun; 3(12):1854-1857. PubMed ID: 31213431
[TBL] [Abstract][Full Text] [Related]
2. Alternate application of all-trans-retinoic acid and arsenic trioxide combined with idarubicin/daunorubicin in treatment of acute promyelocytic leukemia.
Xu X; Mao Y; Zhu X; Tang F
Pak J Pharm Sci; 2022 Jan; 35(1):23-28. PubMed ID: 35221268
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of acute promyelocytic leukaemia without chemotherapy and blood transfusion].
Tøstesen M; Østgård LSG; Kjeldsen E; Stentoft J; Nørgaard JM
Ugeskr Laeger; 2018 Jan; 180(3):. PubMed ID: 29336300
[TBL] [Abstract][Full Text] [Related]
4. Severe myopericarditis following induction therapy with idarubicin and transretinoic acid in a patient with acute promyelocytic leukemia.
Carcelero San Martín E; Riu Viladoms G; Creus Baró N
Med Clin (Barc); 2018 Jun; 150(12):492-493. PubMed ID: 29196036
[No Abstract] [Full Text] [Related]
5. Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia.
Breccia M; Foà R
Expert Rev Hematol; 2019 Feb; 12(2):81-87. PubMed ID: 30572725
[TBL] [Abstract][Full Text] [Related]
6. Outcome of relapsed/refractory acute promyelocytic leukaemia in children, adolescents and young adult patients - a 25-year Italian experience.
Testi AM; Mohamed S; Diverio D; Piciocchi A; Menna G; Rizzari C; Timeus F; Micalizzi C; Lo Nigro L; Santoro N; Masetti R; Micheletti MV; Ziino O; Onofrillo D; Ladogana S; Putti C; Pierani P; Arena V; Zecca M; Foà R; Locatelli F
Br J Haematol; 2021 Oct; 195(2):278-283. PubMed ID: 34145572
[No Abstract] [Full Text] [Related]
7. Switching from all-trans retinoic acid to arsenic trioxide for newly diagnosed acute promyelocytic leukemia.
Imagawa J
Leuk Lymphoma; 2018 Dec; 59(12):3013-3015. PubMed ID: 29616847
[No Abstract] [Full Text] [Related]
8. First report of successful management of acute promyelocytic leukemia in a pregnant female with All-Trans-Retinoic Acid and Arsenic Trioxide-based induction regimen.
Khosla H; Jain A; Tatawadiya S; Prasad P; Nagpal K; Chaudhry S; Sharma M; Gupta DK; Saluja S; Jain A
Blood Cells Mol Dis; 2020 Nov; 85():102476. PubMed ID: 32688220
[No Abstract] [Full Text] [Related]
9. Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin.
Fujisawa T; Takeda J; Aoki K; Ishikawa T
Ann Hematol; 2014 Sep; 93(9):1621-3. PubMed ID: 24399307
[No Abstract] [Full Text] [Related]
10. [Acute promyelocytic leukaemia].
Tøstesen M; Østergård LSG; Kjeldsen E; Stentoft J; Nørgaard JM
Ugeskr Laeger; 2018 Jan; 180(3):. PubMed ID: 29336301
[TBL] [Abstract][Full Text] [Related]
11. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acid.
Nellessen CM; Janzen V; Mayer K; Giovannini G; Gembruch U; Brossart P; Merz WM
Arch Gynecol Obstet; 2018 Feb; 297(2):281-284. PubMed ID: 29110117
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide newly joins treatment strategies for acute promyelocytic leukemia.
Kuriyama K
Intern Med; 2001 Dec; 40(12):1165. PubMed ID: 11813833
[No Abstract] [Full Text] [Related]
14. [Efficacy of Idarubicin-Based Stratified Therapy for Acute Promyelocytic Leukemia].
Guan W; Li WJ; Yang L; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):353-357. PubMed ID: 28446274
[TBL] [Abstract][Full Text] [Related]
15. [Acute Promyelocytic Leukemia: New treatment strategies with ATRA and ATO - AML-BFM-Recommendations].
Creutzig U; Dworzak M; von Neuhoff N; Rasche M; Reinhardt D
Klin Padiatr; 2018 Oct; 230(6):299-304. PubMed ID: 30399642
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
17. Microgranular variant of acute promyelocytic leukemia with cytoplasmic projections resembling micromegakaryocytes.
Jiang W; Lee SH
Blood; 2018 Nov; 132(21):2314. PubMed ID: 30467190
[No Abstract] [Full Text] [Related]
18. Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?
Tsimberidou AM; Kantarjian H; Keating MJ; Estey E
Leuk Lymphoma; 2006 Nov; 47(11):2282-8. PubMed ID: 17107899
[TBL] [Abstract][Full Text] [Related]
19. Use of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone.
Ammatuna E; Montefusco E; Pacilli M; Divona M; Ardiri D; Centonze D; Lo-Coco F
Leuk Lymphoma; 2009 Jul; 50(7):1217-8. PubMed ID: 19479616
[No Abstract] [Full Text] [Related]
20. Flexural Eruption Associated With Arsenic Trioxide Therapy in a Patient With Acute Promyelocytic Leukemia.
Teran VA; Wilson BB; Guffey DJ
JAMA Dermatol; 2019 Mar; 155(3):389-391. PubMed ID: 30673070
[No Abstract] [Full Text] [Related]
[Next] [New Search]